What is the treatment for a urine culture positive for coagulase-negative staphylococcus (CoNS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Coagulase-Negative Staphylococcus in Urine

In most cases, coagulase-negative staphylococci (CoNS) isolated from urine should NOT be treated, as they typically represent contamination or asymptomatic colonization rather than true infection. 1

Determining Clinical Significance

The critical first step is distinguishing true infection from contamination:

  • CoNS are "not considered clinically relevant urine isolates" in the majority of cases, particularly in asymptomatic patients 1
  • A single positive urine culture with CoNS, especially when in-office testing was negative, strongly suggests contamination or colonization rather than infection 1
  • True UTI requires both positive culture AND clinical symptoms (dysuria, frequency, urgency, suprapubic pain, fever, or flank pain) 1

When Treatment IS Indicated

Treatment should only be considered when BOTH of the following are present:

1. Symptomatic Infection

  • Lower tract symptoms: dysuria, frequency, urgency, suprapubic pain 1
  • Upper tract symptoms: fever, flank pain, costovertebral angle tenderness 2
  • Systemic symptoms: rigors, altered mental status, malaise 2

2. High-Risk Clinical Context

Treatment is warranted in patients with: 1

  • Indwelling urinary catheter
  • Recent urological procedure
  • Immunocompromised status
  • Pregnancy
  • Urinary tract abnormalities (especially in young children and males with pyelonephritis) 3

Treatment Regimens When Indicated

For Uncomplicated Cystitis (Symptomatic Lower UTI):

  • Nitrofurantoin for 5 days (first-line) 1
  • TMP/SMX for 3 days (alternative first-line) 1

For Pyelonephritis (Upper UTI):

  • First-generation cephalosporin for 7 days 1

For Catheter-Associated UTI (CAUTI):

When CoNS causes symptomatic CAUTI, management differs significantly:

  • Replace the catheter before starting antibiotics if it has been in place ≥2 weeks 2
  • First-line empirical treatment: IV third-generation cephalosporin 2
  • Alternative options: amoxicillin plus aminoglycoside, OR second-generation cephalosporin plus aminoglycoside 2
  • Duration: 7 days for prompt response; 10-14 days for delayed response; 14 days if prostatitis cannot be excluded in males 2
  • Remove the catheter whenever possible before starting antibiotics 2

For Complicated UTI with Systemic Symptoms:

  • Amoxicillin plus aminoglycoside 1
  • Second-generation cephalosporin plus aminoglycoside 1
  • IV third-generation cephalosporin 1

Critical Caveats

Asymptomatic bacteriuria should NOT be treated (except in pregnancy), as treatment promotes antibiotic resistance without clinical benefit 1

Obtain antimicrobial susceptibility testing when treatment is pursued, as methicillin resistance is common among CoNS 2, 4

In young children with CoNS pyelonephritis, particularly males, investigate for underlying urinary tract abnormalities, as 37% have structural anomalies 3

Avoid fluoroquinolones unless local resistance is <10%, the patient hasn't used them in 6 months, and has β-lactam anaphylaxis 2

Special Populations

Neutropenic Patients:

CoNS bacteremia in neutropenic patients rarely causes rapid deterioration, and vancomycin is not routinely needed at fever onset 5. A single positive blood culture should be dismissed as contamination if repeat cultures are negative 5.

Catheterized Patients:

CoNS in catheterized patients most commonly represents colonization rather than infection 2, 6. Treatment is only indicated with symptoms compatible with CAUTI 2.

References

Guideline

Treatment of Urinary Tract Infection with Coagulase Negative Staphylococci

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Catheter-Related Urinary Tract Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.

Clinical journal of the American Society of Nephrology : CJASN, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Coagulase-negative staphylococci: role as pathogens.

Annual review of medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.